451 related articles for article (PubMed ID: 28664547)
21. Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.
Zhang Y; Chen B; Hou XH; Guan GJ; Liu G; Liu HY; Li XG
Chin Med J (Engl); 2007 Jun; 120(11):988-95. PubMed ID: 17624267
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy.
Jourdan T; Park JK; Varga ZV; Pálóczi J; Coffey NJ; Rosenberg AZ; Godlewski G; Cinar R; Mackie K; Pacher P; Kunos G
Diabetes Obes Metab; 2018 Mar; 20(3):698-708. PubMed ID: 29106063
[TBL] [Abstract][Full Text] [Related]
23. Glucose-induced gradual phenotypic modulation of cultured human glomerular epithelial cells may be independent of Wilms' tumor 1 (WT1).
Tsotakos NE; Sagnou M; Kotsopoulou ES; Tsilibary EC; Drossopoulou GI
BMC Cell Biol; 2013 Jun; 14():28. PubMed ID: 23768159
[TBL] [Abstract][Full Text] [Related]
24. VDR Activation Reduces Proteinuria and High-Glucose-Induced Injury of Kidneys and Podocytes by Regulating Wnt Signaling Pathway.
Guo J; Lu C; Zhang F; Yu H; Zhou M; He M; Wang C; Zhao Z; Liu Z
Cell Physiol Biochem; 2017; 43(1):39-51. PubMed ID: 28848172
[TBL] [Abstract][Full Text] [Related]
25. VDR/Atg3 Axis Regulates Slit Diaphragm to Tight Junction Transition via p62-Mediated Autophagy Pathway in Diabetic Nephropathy.
Wang B; Qian JY; Tang TT; Lin LL; Yu N; Guo HL; Ni WJ; Lv LL; Wen Y; Li ZL; Wu M; Cao JY; Liu BC
Diabetes; 2021 Nov; 70(11):2639-2651. PubMed ID: 34376476
[TBL] [Abstract][Full Text] [Related]
26. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
27. Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.
He W; Kang YS; Dai C; Liu Y
J Am Soc Nephrol; 2011 Jan; 22(1):90-103. PubMed ID: 21030600
[TBL] [Abstract][Full Text] [Related]
28. Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats.
Ahmed OM; Ali TM; Abdel Gaid MA; Elberry AA
PLoS One; 2019; 14(9):e0214349. PubMed ID: 31527864
[TBL] [Abstract][Full Text] [Related]
29. Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy.
Wang Y; Zhou J; Minto AW; Hack BK; Alexander JJ; Haas M; Li YC; Heilig CW; Quigg RJ
Kidney Int; 2006 Sep; 70(5):882-91. PubMed ID: 16820793
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
31. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanism underlying 1,25-dihydroxyvitamin D regulation of nephrin gene expression.
Deb DK; Wang Y; Zhang Z; Nie H; Huang X; Yuan Z; Chen Y; Zhao Q; Li YC
J Biol Chem; 2011 Sep; 286(37):32011-7. PubMed ID: 21803771
[TBL] [Abstract][Full Text] [Related]
33. CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes.
Teng B; Schroder P; Müller-Deile J; Schenk H; Staggs L; Tossidou I; Dikic I; Haller H; Schiffer M
Diabetes; 2016 Dec; 65(12):3667-3679. PubMed ID: 27531950
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptor-δ activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in type 2 diabetes.
Lee EY; Kim GT; Hyun M; Kim S; Seok S; Choi R; Lee MY; Chung CH
Nephrol Dial Transplant; 2012 Nov; 27(11):4069-79. PubMed ID: 22892126
[TBL] [Abstract][Full Text] [Related]
35. IQGAP1 mediates podocyte injury in diabetic kidney disease by regulating nephrin endocytosis.
Liu Y; Su H; Ma C; Ji D; Zheng X; Wang P; Zheng S; Wang L; Wang Z; Xu D
Cell Signal; 2019 Jul; 59():13-23. PubMed ID: 30857827
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D-VDR (vitamin D receptor) regulates defective autophagy in renal tubular epithelial cell in streptozotocin-induced diabetic mice via the AMPK pathway.
Li A; Yi B; Han H; Yang S; Hu Z; Zheng L; Wang J; Liao Q; Zhang H
Autophagy; 2022 Apr; 18(4):877-890. PubMed ID: 34432556
[TBL] [Abstract][Full Text] [Related]
37. Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats.
Deepa B; Venkatraman Anuradha C
Toxicol Mech Methods; 2013 May; 23(4):223-34. PubMed ID: 23193997
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of bradykinin-induced expression of connective tissue growth factor and nephrin in podocytes.
Abou Msallem J; Chalhoub H; Al-Hariri M; Saad L; Jaffa MA; Ziyadeh FN; Jaffa AA
Am J Physiol Renal Physiol; 2015 Dec; 309(11):F980-90. PubMed ID: 26447218
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of tacrolimus on podocytes in early diabetic nephropathy in rats.
Peng T; Chang X; Wang J; Zhen J; Yang X; Hu Z
Mol Med Rep; 2017 May; 15(5):3172-3178. PubMed ID: 28339051
[TBL] [Abstract][Full Text] [Related]
40. Astragalus membranaceus and Panax notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats.
Zhai R; Jian G; Chen T; Xie L; Xue R; Gao C; Wang N; Xu Y; Gui D
J Diabetes Res; 2019; 2019():1602892. PubMed ID: 31179338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
